Idiopathic inflammatory bowel disease – advancements in surgical treatment
Authors:
J. Ulrych; Z. Krška
Authors‘ workplace:
I. chirurgická klinika 1. LF UK a VFN v Praze, přednosta: prof. MUDr. Z. Krška, CSc.
Published in:
Rozhl. Chir., 2012, roč. 91, č. 10, s. 539-544.
Category:
Original articles
Overview
Introduction:
Treatment of idiopathic inflammatory bowel disease is constantly developing. Biological therapy has become a standard part of conservative treatment, and gene and cell therapy of these diseases is in preclinical phase. Surgical therapy also offers some progress in the treatment, such as the increasingly preferred laparoscopic approach offering the numerous benefits of minimally invasive surgery or a tendency to perform stapled anastomosis.
Material and methods:
A retrospective analysis of patients with a diagnosis of idiopathic inflammatory bowel operated on at the First Department of Surgery, General University Hospital in the years 2007–2011 was performed.
Results:
Within this period, 179 patients diagnosed with Crohn’s disease were operated on. 30 patients underwent acute operation and 149 patients were indicated for elective surgery. In the same period, 40 patients with ulcerative colitis were indicated for surgery, of whom 22 patients for acute surgery and 18 for elective surgery.
Conclusion:
Multidisciplinary approach in the treatment of patients with inflammatory bowel disease is crucial and patients should be treated in specialized centres. New possibilities of conservative treatment and progress in surgical therapy mutually correlate, and thus the choice of a correct therapeutic procedure requires specific cooperation between the surgeon and the gastroenterologist.
Key words:
Crohn’s disease – ulcerative colitis – surgery
Sources
1. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60(5):571–607.
2. van Marel S, Majowicz A, van Deventer S, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011;2(6):114–22.
3. Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed) 2010;2:993–1008.
4. Kessler H, Mudter J, Hohenberger W. Recent results of laparoscopic surgery in inflammatory bowel disease. World J Gastroenterol 2011;17(9):1116–25.
5. Casillas S, Delaney CP. Laparoscopic surgery for inflammatory bowel disease. Dig Surg. 2005;22(3):135–42. Epub 2005 Jul 20.
6. Holubar SD, Dozois EJ, Privitera A, Cima RR, Pemberton JH, Young-Fadok T, Larson DW. Laparoscopic surgery for recurrent ileocolic Crohn-disease. Inflamm Bowel Dis 2010;16(8): 1382–6.
7. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, DęHoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, OęMorain C, Oresland T, Windsor A, Stange EF, Travis SP; European Crohnęs and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn-disease: Current management. J Crohns Colitis 2010;4(1):28–62. Epub 2010 Jan 15.
8. Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohnęs disease. Dis Colon Rectum 2007;50(10):1674–87.
9. Choy PY, Bissett IP, Docherty JG, Parry BR, Merrie A, Fitzgerald A. Stapled versus handsewn methods for ileocolic anastomoses. Cochrane Database Syst Rev. 20117;9:CD004320.
10. MuĖoz-Juárez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum 2001;44(1):20–5 discussion 25–6.
11. Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. Other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum 2007;50(10):1674–87.
12. Alessandroni L, Bertolini R, Campanelli A, Capaldi M, Di Castro A, Mencacci R, Natuzzi G, Cecera A, Tersigni R. Role of anastomotic configuration in ileocolic resection for Crohn’s disease. Chir Ital 2009;61(1):23–31.
13. Krska Z, Sváb J, Lukás M, Pesková M. Idiopatic bowel disease. Rozhl Chir 2006;85(5):244–8.
14. Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of infliximab. Ann Surg 2010;252(2):307–12.
15. Slattery E, Keegan D, Hyland J, O’Donoghue D, Mulcahy HE. Surgery, Crohn’s disease, and the biological era: has there been an impact? J Clin Gastroenterol 2011;45(8):691–3.
16. Behm BW, Bickston SJ. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893.
17. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. ACCENT I Study Group. Maintenance infliximab for Crohnęs disease: the ACCENT I randomised trial. Lancet 2002;359(9317):1541–9.
18. Zerbib P, Koriche D, Truant S, Bouras AF, Vernier-Massouille G, Seguy D, Pruvot FR, Cortot A, Colombel JF. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn’s disease. Aliment Pharmacol Ther 2010;32(3):459–65. Epub 2010 May 22.
19. del Val JH. Old-age inflammatory bowel disease onset: a different problem? World J Gastroenterol. 2011;17(22):2734–9.
20. Berg DF, Bahadursingh AM, Kaminski DL, Longo WE. Acute surgical emergencies in inflammatory bowel disease. Am J Surg. 2002;184(1):45–51.
21. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of stricturoplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 2007;50(11):1968–86.
22. Menon AM, Mirza AH, Moolla S, Morton DG. Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohnęs disease: report of a case. Dis Colon Rectum 2007;50 (2):257–9.
23. Andersson P, Olaison G, Hallböök O, Sjödahl R. Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 2002;45(1):47–53.
24. Yamamoto T. Factors affecting recurrence after surgery for Crohnęs disease. World J Gastroenterol 2005;11(26):3971–9.
25. Ajlouni Y, Iser JH, Gibson PR. Endoscopic balloon dilatation of intestinal strictures in Crohn’s disease: safe alternative to surgery. J Gastroenterol Hepatol 2007;22(4):486–90.
26. Van Assche G, Vermeire S, Rutgeerts P. Endoscopic therapy of strictures in Crohn’s disease. Inflamm Bowel Dis 2007;13 (3):356–8; discussion 362–3.
27. Cima RR. Timing and indications for colectomy in chronic ulcerative colitis: Surgical consideration. Dig Dis 2010;28(3): 501–7.Epub 2010 Sep 30.
28. Andersson P, Söderholm JD. Surgery in ulcerative colitis: indication and timing. Dig Dis 2009;27(3):335–40. Epub 2009; Sep 24.
29. Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, Colombel JF. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol 2006;30(4):594–7.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2012 Issue 10
Most read in this issue
- Traumatic rupture of thoracic aorta
- Anaplastic carcinoma of the thyroid gland
- Catamenial pneumothorax – case studies from our department in a ten-year period
- Idiopathic inflammatory bowel disease – advancements in surgical treatment